These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4246294)

  • 21. Interactions between tubocurarine, pancuronium and alcuronium demonstrated in the rat phrenic nerve-hemidiaphragm preparation.
    Pollard BJ; Jones RM
    Br J Anaesth; 1983 Nov; 55(11):1127-31. PubMed ID: 6315037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The non-depolarizing myorelaxants in orotracheal intubation. A clinical comparison].
    Ravagnan R; Russo R; Buzzetti V; Elena A; Colombo A; Pelosi P; Iapichino G
    Minerva Anestesiol; 1989 Nov; 55(11):467-71. PubMed ID: 2576685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QT interval of the ECG, heart rate and arterial pressure using five non-depolarizing muscle relaxants for intubation.
    Saarnivaara L; Klemola UM; Lindgren L
    Acta Anaesthesiol Scand; 1988 Nov; 32(8):623-8. PubMed ID: 2905566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of intercompartmental disposition and excretion of tubocurarine, gallamine, alcuronium and pancuronium in patients with normal and impaired renal function.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jul; 27(7):319-21. PubMed ID: 150805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-response curves for four neuromuscular blockers using continuous i.v. infusion.
    Shanks CA; Walker JS; Ramzan MI; Triggs EJ
    Br J Anaesth; 1981 Jun; 53(6):627-33. PubMed ID: 7248126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unequal effects of cardiopulmonary bypass-induced hypothermia on neuromuscular blockade from constant infusion of alcuronium, d-tubocurarine, pancuronium, and vecuronium.
    Buzello W; Schluermann D; Pollmaecher T; Spillner G
    Anesthesiology; 1987 Jun; 66(6):842-6. PubMed ID: 2884901
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative use of muscle relaxants and their reversal in three European countries: a survey in France, Germany and Great Britain.
    Osmer C; Vogele C; Zickmann B; Hempelmann G
    Eur J Anaesthesiol; 1996 Jul; 13(4):389-99. PubMed ID: 8842663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is succinylcholine after pretreatment with d-tubocurarine and lidocaine contraindicated for outpatient anesthesia?
    Mikat-Stevens M; Sukhani R; Pappas AL; Fluder E; Kleinman B; Stevens RA
    Anesth Analg; 2000 Aug; 91(2):312-6. PubMed ID: 10910840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dose-effect relationship of metocurine: EMG versus MMG.
    Eisenkraft JB
    Anesthesiology; 1988 Nov; 69(5):807-8. PubMed ID: 2973267
    [No Abstract]   [Full Text] [Related]  

  • 30. Intratracheal muscle relaxants--a possible route.
    Simionescu R; Bandila T
    Anaesthesia; 1989 Mar; 44(3):264. PubMed ID: 2523204
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine.
    Miller RD; Larson CP; Way WL
    Anesthesiology; 1972 Nov; 37(5):503-9. PubMed ID: 4263447
    [No Abstract]   [Full Text] [Related]  

  • 32. Priming with nondepolarizing relaxants for rapid tracheal intubation: a double-blind evaluation.
    Baumgarten RK; Carter CE; Reynolds WJ; Brown JL; DeVera HV
    Can J Anaesth; 1988 Jan; 35(1):5-11. PubMed ID: 2894903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differing interactions between hexamethonium and tubocurarine, pancuronium or alcuronium at the neuromuscular junction.
    Pollard BJ; van der Spek AF
    Br J Anaesth; 1988 Oct; 61(4):419-24. PubMed ID: 2903757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immediate cardiovascular effects of pancuronium, alcuronium and tubocurarine in man.
    Coleman AJ; Downing JW; Leary WP; Moyes DG; Styles M
    Anaesthesia; 1972 Oct; 27(4):415-22. PubMed ID: 4264060
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of tubocurarine and alcuronium on suxamethonium-induced changes in cardiac rate and rhythm.
    Karhunen U; Heinonen J; Tammisto T
    Acta Anaesthesiol Scand; 1972; 16(1):3-10. PubMed ID: 4262580
    [No Abstract]   [Full Text] [Related]  

  • 36. Initial experience during the clinical use of pancuronium bromide.
    McIntyre JW; Gain EA
    Anesth Analg; 1971; 50(5):813-23. PubMed ID: 4255896
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of the skeletal neuromuscular and autonomic ganglion-blocking potencies of five non-depolarizing relaxants.
    Birmingham AT; Hussain SZ
    Br J Pharmacol; 1980 Nov; 70(3):501-6. PubMed ID: 6108148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-response curves for pancuronium and tubocurarine: comparison of single and cumulative dose techniques.
    Gibson FM; Mirakhur RK
    Eur J Anaesthesiol; 1987 Mar; 4(2):143-7. PubMed ID: 3595574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical comparison of D-tubocurarine and pancuronium: dosage schedule based on lean body mass.
    Nickorick E; Reynolds FB
    Can Anaesth Soc J; 1973 Mar; 20(2):217-26. PubMed ID: 4266004
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of four non-depolarizing neuromuscular blocking drugs in the suppression of the oculocardiac reflex during strabismus surgery in children.
    Karhunen U; Nilsson E; Brander P
    Br J Anaesth; 1985 Dec; 57(12):1209-12. PubMed ID: 2867772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.